Application of the Fecal MicroRNA Test to the Residuum from the Fecal Occult Blood Test
Open Access
- 14 May 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 43 (7) , 726-733
Abstract
Though the fecal occult blood test is used for colorectal cancer screening worldwide, it does not have a particularly high sensitivity for detecting colorectal cancer. Here we investigated the applicability of the fecal microRNA test to fecal samples that had been used for a previous fecal occult blood test and stored under various conditions. Five colorectal cancer patients and five healthy volunteers were enrolled. Fecal samples were stored for 0–5 days at 4°C, room temperature or 37°C. Total RNA was extracted from the fecal occult blood test residuum and microRNA expression was analyzed by real-time reverse transcription polymerase chain reaction. There were no remarkable differences either in colorectal cancer patients or in controls with regard to the concentration of RNA extracted from the fecal occult blood test residuum in any of the storage groups compared with the samples prepared on day 0 (Group 0). Ribosomal RNA stored at room temperature or 37°C degraded rapidly. In contrast, the ribosomal RNA stored at 4°C remained intact for at least 5 days. The microRNAs in samples stored at 4°C and room temperature were conserved; however, the microRNAs stored at 37°C were significantly degraded compared with Group 0 (P < 0.05). In the residuum stored at 4°C up to 5 days, the relative quantification of miR-106a normalized with miR-24 in colorectal cancer patients was significantly higher than those in healthy volunteers (P < 0.05). In contrast, the quantification of normalized miR-106a was remarkably low in samples stored at room temperature and 37°C. Fecal microRNA of sufficient quality for reverse transcription polymerase chain reaction analysis was extracted from the fecal occult blood test residuum stored at 4°C for up to 5 days.Keywords
This publication has 28 references indexed in Scilit:
- Fecal MicroRNAs as Novel Biomarkers for Colon Cancer ScreeningCancer Epidemiology, Biomarkers & Prevention, 2010
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- A Comparison of the Immunochemical Fecal Occult Blood Test and Total Colonoscopy in the Asymptomatic PopulationGastroenterology, 2005
- Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk PopulationNew England Journal of Medicine, 2004
- MicroRNAsCell, 2004
- Screening for colorectal cancer in Chinese: Comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopyGastroenterology, 2003
- Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trialGut, 2002
- A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening roundsGut, 2002
- One-Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal ColonNew England Journal of Medicine, 2001
- Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult BloodJNCI: Journal of the National Cancer Institute, 1999